➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Moodys
AstraZeneca
Johnson and Johnson
Colorcon

Last Updated: July 31, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ROXADUSTAT


Email this page to a colleague

« Back to Dashboard

Clinical Trials for Roxadustat

Trial ID Title Status Sponsor Phase Summary
NCT01630889 ↗ Open Label Extension Study for the Long-term Efficacy and Safety of FG-4592 in Dialysis and Non-dialysis Chronic Kidney Disease Patients Enrolling by invitation FibroGen Phase 2/Phase 3 The purpose of this open-label extension study is to evaluate long-term efficacy and safety of FG-4592 in maintaining hemoglobin in dialysis and non-dialysis CKD patients who have completed the Treatment Period of an FG-4592 FibroGen-sponsored anemia study.
NCT01750190 ↗ A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis Recruiting Astellas Pharma Europe B.V. Phase 3 The purpose of this study is to determine whether FG-4592 is safe and effective in the treatment of anemia in chronic kidney disease patients who are not on dialysis.
NCT01750190 ↗ A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis Recruiting AstraZeneca Phase 3 The purpose of this study is to determine whether FG-4592 is safe and effective in the treatment of anemia in chronic kidney disease patients who are not on dialysis.
NCT01750190 ↗ A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis Recruiting FibroGen Phase 3 The purpose of this study is to determine whether FG-4592 is safe and effective in the treatment of anemia in chronic kidney disease patients who are not on dialysis.
NCT01887600 ↗ Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis Recruiting FibroGen Phase 3 This study is conducted to treat anemia in patients with chronic kidney disease. Anemia is a reduced number of red blood cells or hemoglobin. Hemoglobin is important for the transport of oxygen in your blood. The purpose of the study is to see if Roxadustat is both effective and safe as a treatment for anemia in patients with chronic kidney disease.
NCT01887600 ↗ Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis Recruiting Astellas Pharma Europe B.V. Phase 3 This study is conducted to treat anemia in patients with chronic kidney disease. Anemia is a reduced number of red blood cells or hemoglobin. Hemoglobin is important for the transport of oxygen in your blood. The purpose of the study is to see if Roxadustat is both effective and safe as a treatment for anemia in patients with chronic kidney disease.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Roxadustat

Condition Name

Condition Name for
Intervention Trials
Anemia 4
Healthy Subjects 3
Chronic Kidney Disease 2
Anemia Associated With Chronic Kidney Disease 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for
Intervention Trials
Anemia 22
Renal Insufficiency, Chronic 11
Kidney Diseases 11
Kidney Failure, Chronic 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Roxadustat

Trials by Country

Trials by Country for
Location Trials
United States 133
China 20
Canada 15
Spain 13
Mexico 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for
Location Trials
Texas 8
California 8
New York 6
Missouri 6
Louisiana 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Roxadustat

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 4 4
Phase 3 14
Phase 2/Phase 3 2
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Recruiting 14
Not yet recruiting 9
Completed 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Roxadustat

Sponsor Name

Sponsor Name for
Sponsor Trials
FibroGen 22
AstraZeneca 12
Astellas Pharma Europe B.V. 10
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for
Sponsor Trials
Industry 49
Other 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Moodys
AstraZeneca
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.